TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option

Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High Risk

NAV · 06-Jul-2026

₹31.6581

+6.04%

+3.88%

1Y (CAGR)

+3.58%

3Y (CAGR)

+19.97%

5Y (CAGR)

+12.45%

Since inception (CAGR)

+11.51%

NAV history

hover for values

Risk & SIP analytics

Q1 · TOP · 3Y in category

Volatility (3y)

13.53%

Downside dev (3y)

9.65%

Max drawdown (3y)

-17.0%

Sharpe (3y)

1.00

SIP XIRR (3y)

+10.40%

SIP XIRR (5y)

+15.27%

Calendar-year returns

2020 +64.4%2021 +19.1%2022 -8.0%2023 +36.6%2024 +40.4%2025 -4.9%

Fund facts

Fund managerRajat Srivastava

AUM₹13,869 Cr

Launch date04-Dec-2015

Plan typeOpen Ended · Equity

Min lumpsumRs.5000 & in multiples of Re.1/- thereafter.

Lock-inNone

Volatility15.38

AMCTata Asset Management Limited

Objective · The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

scheme documents ↗